A large number of consumables national and local unified collection

a unified set of sets like a crown brace or normalize.

1, the state and local at the same time to promote the collection of consumablesOn the evening of January 15th, CCTV Focus interview column reported on the news about "after the purchase of the crown vein bracket group", according to Saibai Blue equipment observation, from November 5, 2020, China's first centralized belt procurement of crown stent, to this day, has passed 72 days.Whether the next step of the country will continue to expand the collection, which varieties will enter the collection, this is the industry's most discussed topic.According to CCTV news reports, in the future, will be in this national organization of high-value medical supplies crown stent belt procurement on the basis of the field of pharmaceutical supplies belt procurement will also continue.Dong Zhaoxuan, Deputy Director of the Tendering and Procurement Department of the Price Recruitment Department of the State Health Security Administration, said: "In the field of pharmaceuticals will be normal to carry out centralized belt procurement, it is expected that two batches of belt procurement will be carried out each year; "2, the circulation field "with gold sales" has been a long time10 varieties won the bid, the price from the average price of 13,000 yuan to about 700 yuan, crown brace one Subs from the "ceiling price" down to the "floor price", from January 1 this year, the national organization of the crown vein bracket centralized belt procurement results have been in Beijing, Tianjin, Liaoning, Hunan and other provinces and cities to implement, many patients with the price reduction of the crown vein bracket.The question follows, why can the price of the crown bracket be reduced so much? Will it be cheap and not good? How much benefits do patients get?Take the crown stent as an example, in 2019, the national crown stent use more than 1.6 million, the cost of more than 15 billion yuan, only one variety accounted for more than 10% of the total market value of medical supplies, and compared with the international price of similar products, the price is significantly higher.At the same time, high-value medical supplies prices and sales methods are closely related, production enterprises to produce products, sold by agents, after layers of agents, high-value supplies factory prices and the use of the final people prices vary widely.Chen Jinfu, deputy director of the State Administration of Medical Security, said: "High-value medical supplies in the field of falsely high costs, the circulation of the field of "gold sales" disease has been a long time, resulting in a high burden on the people, clinical use of drugs, including supplies is very chaotic." Based on this problem, the national decision-making to carry out high-value medical supplies. " 3, the winning bid is basically the mainstream productsAccording to Seber Blue equipment observation, in this collection procurement of a total of 11 enterprises 26 kinds of crown support to participate in this centralized procurement. Through competition, the collection produced 10 products to be selected, belonging to 8 domestic and foreign enterprises.On November 5, 2020, the State Health Insurance Administration gathered 80% of the national demand for chrome crown braces as the target, 1.07 million in volume exchange, centralized bidding and procurement, independent quotations, low-cost winning bid.Dong Zhaoxuan said: "The original ten largest sales of products, this time seven winning bids, and including the first sales, and from the enterprise point of view, the original market three largest domestic enterprises and two major multinational companies have products have won the bid, so this winning bid is basically mainstream products."medical device company said they were also under pressure from the amount of energy they put on the marketing process. Inflated prices can not only lead to overuse, but also to the side of some patients, as is evident in coronary stent intervention surgery.This time the centralized belt procurement, crown bracket price from the average price of about 13,000 yuan to about 700 yuan, compared with 2019, the same enterprises of the same products reduced by an average of 93%, domestic products reduced by an average of 92%, imported products reduced by an average of 95%. Whether the price decreases will affect the quality of products in the future is also a matter of widespread concern.

4, how to ensure quality?   With volume procurement so that enterprises save the cost of circulation links, can be more focused on production and research and development, but also let the price of crown stents significantly reduced, according to the amount of intention to purchase, estimated to save the relevant costs of 11.7 billion yuan, and this also means that clinical treatment of patients improved access.   Patients are concerned about prices, and it's natural to be happy to cut prices, but before that, doctors have their concerns. Yang Weixian, vice president of the Hospital of the Chinese Academy of Medical Sciences, said: "Don't cause some problems in product quality after the bracket price reduction, or find some problems in the use, which is our more concern."   "Because the tender is a low-cost winning bid, we are most worried about attracting some of the clinical data we have not used, all aspects of clinical data are not particularly solid, " said Du Kefei, deputy director of the Coronary Heart Disease Center at the Chinese Academy of Medical Sciences. " quality after the price of the product has been reduced?"   "Every enterprise has submitted a commitment to ensure quality and a commitment to legal effect, " said Ding Erlei, deputy director of the price recruitment department of the State Administration of Health And Social Security. In addition, from the quality supervision, on the day of the 'double eleven' the State Drug Administration also issued a special notice, for all selected enterprises to carry out another round of full-coverage sampling. "

5, how much can patients save?"   High-quality and inexpensive coronary stents can benefit more patients, so, with the cost of coronary stents falling, a surgery down, patients pay less for surgery?   Dong Zhaoxuan said: "The average cost of coronary stent implantation is 56,000 yuan, after this collection, the cost of the stent average of 1.5 stents per operation, from the original 16,000 yuan to about 1000 yuan, the overall savings of 15,000 yuan." Employee health insurance patients pay 40%, one operation down, save 6000 yuan of personal payments; The surgery is made up of health insurance payments and individual out-of-home payments, and while individual out-of-home payments are reduced, there are savings for the state.   Dong Zhaoxuan said: "For example, the original use of 10,000 brackets, each stent is 10,000 yuan, now become 700 yuan a, the use of stents because there is no overuse, the use of stents into 9000, the original is 10,000 times 10,000 this money, now is 700 times 9000, this time there is a balance of money, then balance of money, first of all, the patient's out-of-pocket costs reduced, the second is the cost of health insurance savings, because of the hospital to pay less money." experts said that we should establish a performance incentive mechanism that reflects the value of medical personnel, and further mobilize the enthusiasm of medical personnel.   "We have established an incentive mechanism, which is to retain the balance, " Dong said. The balance of money at the time of medical insurance and hospital settlement will be partly left to medical institutions after examination, and medical institutions will be encouraged to establish an internal assessment mechanism to pay the balance to medical personnel as a doctor's salary and benefits. It is hoped that this reform will be truly supported by medical personnel, so that medical personnel will become practitioners of the reform. " (Seber Blue)